Enlivex Finalizes 1-for-15 Reverse Stock Split, Effective July 9th, to Address Nasdaq Compliance
ENLV is trading near its 52-week low of $0.509 (10% below the low).
Summary
Enlivex Ltd. announced a 1-for-15 reverse stock split, effective July 9, 2026, a critical step to meet Nasdaq's minimum bid price requirement after receiving a non-compliance notice.
Key Events · Corporate Governance and Compliance · ENLV
-
Reverse Split Finalized
The Board of Directors approved a 1-for-15 reverse stock split, effective July 9, 2026, following shareholder authorization on February 3, 2026.
-
Nasdaq Compliance Action
This action directly addresses a Nasdaq notice received on May 15, 2026, regarding the company's failure to meet the minimum $1.00 bid price requirement.
-
Share Structure Adjustment
Outstanding shares will decrease from 252.5 million to approximately 16.8 million, with authorized shares also reduced proportionally. Fractional shares will be rounded up.
-
Trading Below 52-Week Low
The company's stock is currently trading at $0.456, which is below its 52-week low of $0.5089, highlighting the urgency of the reverse split for listing compliance.
Analysis · ENLV · Life Sciences
Enlivex's decision to implement a 1-for-15 reverse stock split is a critical move to regain compliance with Nasdaq's minimum bid price requirement, following a notice received on May 15, 2026. This action, while necessary for continued listing, typically signals underlying challenges and is often viewed negatively by the market, especially as the stock is currently trading below its 52-week low. The split will drastically reduce the number of outstanding shares and increase the per-share price, but does not change the company's overall market valuation.
At the time of this filing, ENLV was trading at $0.46 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $123.4M. The 52-week trading range was $0.51 to $2.10. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.